3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Colonic Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Vitamin D Deficiency
1
Renal Insufficiency, Chronic
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Osteoporosis
1
Obesity
1
Neurofibromatosis 1
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Musculoskeletal Diseases
1
Melanoma
1
Locally Advanced Breast Cancer and Large Operable Breast Cancer
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Healthy, no Evidence of Disease
1
Congenital Abnormalities
1
Cardiovascular Diseases
1
Interventions
Epoetin Alfa
9
Darbepoetin alfa
5
epoetin beta
3
telapristone acetate
2
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
Busulfan
2
AP 1903 reagent
2
ACE-011
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
venetoclax
1
vactosertib
1
trametinib
1
thymoglobulin
1
ruxolitinib
1
regorafenib
1
ponatinib
1
pertuzumab
1
pembrolizumab
1
peginesatide
1
palbociclib
1
olaparib
1
niraparib
1
neratinib
1
lorlatinib
1
lenvatinib
1
idelalisib
1
hematide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Anemia
×
Cholecalciferol
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled